drugset / Trial / NCT04063527
Phase III Trial of Stage I Ovarian Cancer After Surgery
Phase 3
Recruiting
360 enrolled
Japanese Gynecologic Oncology Group
Korean Gynecologic Oncology Group · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
To compare the Overall survival of adjuvant chemotherapy versus observation in stage I epithelial ovarian cancer after comprehensive staging surgery
Timeline
- Start
- 2012-07-20
- Primary completion
- 2029-10-01
- Completion
- 2030-02-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Carboplatin | Small molecule | — | — |
| Comparator | Paclitaxel | Small molecule | 175 mg/m2 | — |